GlobeNewswire Inc | Mar 11, 2021 08:45AM EST

March 11, 2021

TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire- Avicanna (AVCNF) today announced that Aras Azadian, CEO, will be attending the Q1 Virtual Investor Summit.

Event Q1 Investor Summit Date March 23-25th, 2021 Presentation March 24th @ 2:00PM ET Location https://zoom.us/webinar/register/WN_gqM8YnegRIqpec0qI9JuVw



About The Investor SummitThe Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com

Contact: Brittney Blocker at brittney@investorsummitgroup.com

ABOUT Avicanna Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.Wire Service Contact:

InvestorWire (IW)

Los Angeles, California

www.InvestorWire.com

212.418.1217 Office

Editor@InvestorWire.com